Moderna Stock Price

17.85 (16.35%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
17.85 16.35% 127.03 17:00:00
Open Price Low Price High Price Close Price Previous Close
115.12 114.8601 130.00 127.03 109.18
Bid Price Ask Price Spread News
128.15 128.40 0.25 1 3
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
396,219 43,438,536 $ 125.36 $ 5,445,560,863 12,837,901 17.68 - 130.06
Last Trade Time Type Quantity Stock Price Currency
16:59:46 formt 150 $ 128.40 USD

Moderna Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 50.27B 395.71M 304.03M $ 60.21M $ - -1.54 -61.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -497.58k 5.50%

more financials information »

Moderna News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week94.99130.0693.54102.8117,339,19532.0433.73%
1 Month70.80130.0666.5590.9916,893,57956.2379.42%
3 Months64.27130.0654.2179.7010,644,44562.7697.65%
6 Months51.20130.0646.130173.6116,641,20775.83148.11%
1 Year20.28130.0617.6859.6914,937,912106.75526.38%
3 Years22.00130.0611.5455.898,435,128105.03477.41%
5 Years22.00130.0611.5455.898,435,128105.03477.41%

Moderna Description

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life. The firm is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases. Its clinical trials include mRNA-1647, mRNA-1893, mRNA-4157, and mRNA-2416 among others.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.